Subtractive genomics approach to identify putative drug targets and identification of drug-like molecules for beta subunit of dna polymerase iii in streptococcus species

Applied Biochemistry and Biotechnology

Volumn 167, Issue 5, 2012, Pages 1377-1395

  Georrge, John J ^a   Umrania, V V ^b  

^a Christ College   (India)

^b MVM Sc and HSc College   (India)

Author keywords

ADMET; BLAST; DEG; Docking; Homologous proteins; KAAS Server; Modeling; Potential drug targets; Reverse vaccinology; Streptococcus species

Indexed keywords

ADMET; BLAST; DEG; HOMOLOGOUS PROTEINS; POTENTIAL DRUG; STREPTOCOCCUS SPECIES; VACCINOLOGY;

BACTERIOLOGY; BIOINFORMATICS; DNA; DOCKING; ECOLOGY; GENES; MICROORGANISMS; MODELS; MOLECULES; POLYMERS; THREE DIMENSIONAL;

LIGANDS;

BACTERIAL ENZYME; DNA DIRECTED DNA POLYMERASE GAMMA; DNA DIRECTED DNA POLYMERASE GAMMA BETA SUBUNIT; UNCLASSIFIED DRUG;

BACTERIAL GENOME; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DEVELOPMENT; ENZYME STRUCTURE; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANIMALS; ANTI-BACTERIAL AGENTS; DNA POLYMERASE III; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; GENOMICS; HOST-PATHOGEN INTERACTIONS; MODELS, MOLECULAR; MOLECULAR TARGETED THERAPY; PROTEIN CONFORMATION; PROTEIN TRANSPORT; RATS; STREPTOCOCCUS; SUBCELLULAR FRACTIONS;

POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 84866434750     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-012-9620-0     Document Type: Conference Paper

References (76)

1. De Groot, A. S., et al. (2002). Immunology and Cell Biology, 80, 255-269.
2. Galperin, M. Y., & Koonin, E. V. (1999). Current Opinion in Biotechnology, 10, 571-578.
3. Koonin, E. V., et al. (1998). Current Opinion in Structural Biology, 8, 355-363.
4. Barh, D., et al. (2011). Drug Development Research, 72, 162-177.
5. Kanehisa, M., et al. (2010). Nucleic Acids Research, 38(Database issue), D355-D360.
6. Zhang, R., & Lin, Y. (2009). Nucleic Acids Research, 37, D455-D458.
7. Amineni, U., Pradhan, D., & Marisetty, H. (2010). Journal of Chemical Biology, 3(4), 165-173.
8. Rathi, B., et al. (2009). Bioinformation, 4(4), 143-150.
9. Koteswara Reddy, G., et al. (2010). International Journal of Bioinformatics Research, 2(2), 12-16.
10. Dutta, A., et al. (2006). In Silico Biology, 6(1-2), 43-47.
11. Sakharkar, K. R., et al. (2004). In Silico Biology, 4(3), 355-360.
12. Gupta, S. K., et al. (2010). Journal of Antivirals & Antiretrovirals, 2, 038-042.
13. Allsop, A. E., et al. (1995). Bioorganic & Medicinal Chemistry Letters, 5, 443-448.
14. Sharma, V., et al. (2008). In Silico Biology, 8(3-4), 331-338.
15. Barh, D., & Kumar, A. (2009). In Silico Biology, 9(4), 225-231.
16. Singh, S., et al. (2007). Journal of Bioinformatics and Computational Biology, 5(1), 135-153.
17. Anishetty, S., et al. (2005). Computational Biology and Chemistry, 29(5), 368-378.
18. May, J. J., et al. (2005). FEBS Journal, 272(12), 2993-3003.
19. Marrone, T. J., et al. (1997). Annual Review of Pharmacology and Toxicology, 37, 71-90.
20. Ryan, K. J., Ray, C. G. (2004) Sherris Medical microbiology (4th ed. ed.). (McGraw Hill) ISBN 0-8385-8529-9.
21. Patterson, M. J. (1996). Streptococcus. In: S. Baron et al. (Ed.), Baron's Medical Microbiology (4th ed.). Univ of Texas Medical Branch.
22. Albrich, W. C., Monnet, D. L., & Harbarth, S. (2004). Emerging Infectious Diseases, 10(3), 514-517.
23. Reinert, R. R., et al. (2004). International Journal of Antimicrobial Agents, 24(1), 43-47.
24. Gottschalk, B., et al. (2006). Journal of Bacteriology, 188(16), 5984-5992.
25. Nagai, K., et al. (2002). Antimicrobial Agents and Chemotherapy, 46(5), 1273-1280.
26. Byeon, W. H., & Weisblum, B. (1984). Journal of Bacteriology, 158(2), 543-550.
27. Knox, C., et al. (2011). Nucleic Acids Research, 39(Database issue), D1035-D1041.
28. Huang, Y., et al. (2010). Bioinformatics, 26(5), 680-682.
29. Wood, T. C., & Pearson, W. R. (1999). Journal of Molecular Biology, 291(4), 977-995.
30. Krissinel, E. (2007). Bioinformatics, 23(6), 717-723.
31. Online: www.ncbi.nlm.nih.gov/genome/seq/BlastGen/BlastGen.cgi?taxid09606
32. Moriya, Y., et al. (2007). Nucleic Acids Research, 35(Web Server issue), W182-W185.
33. Chen, X., Ji, Z. L., & Chen, Y. Z. (2002). Nucleic Acids Research, 30(1), 412-415.
34. Gao, Z., et al. (2008). BMC Bioinformatics, 9, 104.
35. Ye, H., et al. (2011). Nucleic Acids Research, 39(Database issue), D1055-D1059.
36. Yu, N. Y., et al. (2010). Bioinformatics, 26(13), 1608-1615.
37. Krogh, A., et al. (2001). Journal of Molecular Biology, 305(3), 567-580.
38. Roy, A., et al. (2010). Nature Protocols, 5, 725-738.
39. Laskowski, R. A., et al. (1993). Journal of Applied Crystallography, 26, 283-291.
40. Melo, F., & Feytmans, E. (1998). Journal of Molecular Biology, 277(5), 1141-1152.
41. Hendlich, M., et al. (1997). Journal of Molecular Graphics and Modelling, 15359-15363.
42. Levitt, D. G., & Banaszak, L. J. (1992). Journal of Molecular Graphics and Modelling, 10229-10234.
43. Laurie, A. T., & Jackson, R. M. (2005). Bioinformatics, 21, 1908-1916.
44. Maestro, version 9.0, Schrödinger, LLC, New York, NY, 2009 45. Thomsen, R., & Christensen, M. H. (2006). Journal of Medicinal Chemistry, 49(11), 3315-3321.
45. QikProp, version 3.2, Schrödinger, LLC, New York, NY, 2009
46. TOPKAT, San Diego, CA: Accelrys, Inc
47. Greene, N. (2002). Advanced Drug Delivery Reviews, 54, 417-431.
48. World Health Organization (2002). The World Health Report.
49. Spellberg, B., et al. (2004). Clinical Infectious Diseases, 38, 1279-1286.
50. Bansal, A. K. (2005). Microbial Cell Factories, 4, 19.
51. Barreteau, H., et al. (2008). FEMS Microbiology Reviews, 32(2), 168-207.
52. Bouhss, A., et al. (2008). FEMS Microbiology Reviews, 32(2), 208-233.
53. Rogers, H. J., & Perkins, H. R. (1968). Cell Walls and Membranes. London: Spon.
54. Tchieu, J. H., et al. (2001). Journal of Molecular Microbiology and Biotechnology, 3(3), 329-346.
55. Kotrba, P., et al. (2001). Journal of Bioscience and Bioengineering, 92(6), 502-517.
56. Driessen, A. J., & Nouwen, N. (2008). Annual Review of Biochemistry, 77, 643-667.
57. Nakatogawa, H., et al. (2004). Current Opinion in Microbiology, 7(2), 145-150.
58. Tomii, K., & Kanehisa, M. A. (1998). Genome Research, 8(10), 1048-1059.
59. Gotoh, Y., et al. (2010). Current Opinion in Microbiology, 13(2), 232-239.
60. Jana, S., & Paliwal, J. (2007). International Journal of Antimicrobial Agents, 30(1), 4-10.
61. Overington, J. P., et al. (2006). Nature Reviews. Drug Discovery, 5(12), 993-996.
62. Bello, A. M., et al. (2009). Journal of Medicinal Chemistry, 52(6), 1648-1658.
63. Wills, E. A., et al. (2001). Molecular Microbiology, 40(3), 610-620.
64. Kulanthaivel, P., et al. (2004). Journal of Biological Chemistry, 279(35), 36250-36258.
65. Gardy, J. L., & Brinkman, F. S. L. (2006). Nature Reviews Microbiology, 4, 741-751.
66. Rappuoli, R. (2000). Current Opinion in Microbiology, 3(5), 445-450.
67. Pizza, M., et al. (2000). Science, 287(5459), 1816-1820.
68. Wijffels, G., et al. (2011). Journal of Medicinal Chemistry, 54(13), 4831-4838.
69. Berdis, A. J. (2008). Biochemistry, 47(32), 8253-8260.
70. Oberg, B. (2006). Antiviral Research, 71(2-3), 90-95.
71. Fang, J., et al. (2011). Biochemistry, 50(26), 5958-5968.
72. Morris, A. L. (1992). Proteins, 12(4), 345-364.
73. Imming, P., Sinning, C., & Meyer, A. (2006). Nature Reviews. Drug Discovery, 5(10), 821-834.
74. White, L. K., et al. (2007). Antimicrobial Agents and Chemotherapy, 51(7), 2293-2303.
75. Tarbouriech, N. (2005). Acta Crystallographica Section D: Biological Crystallography, 61(Pt2), 194-197.
76. Togni, G., et al. (2011) Antimicrobial Agents and Chemotherapy. 2011 Feb 14.